Li Wang

State Key Laboratory Of Medical Genomics, No. 197 Ruijin Second Road
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Low expression of ALOX15B modulates immunosuppressive tumor microenvironment in diffuse large B-cell lymphoma via the TAP1/MHC-I axis.

Low expression of ALOX15B modulates immunosuppressive tumor microenvironment in diffuse large B-cell lymphoma via the TAP1/MHC-I axis.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 10, 2025

A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma.

A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma.

Journal: Cell reports. Medicine

Published: March 25, 2025

Characteristics and predictive model for diffuse large B-cell lymphoma with early chemoimmunotherapy failure.

Characteristics and predictive model for diffuse large B-cell lymphoma with early chemoimmunotherapy failure.

Journal: Frontiers in immunology

Published: January 03, 2025

Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study.

Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study.

Journal: Clinical and translational medicine

Published: November 20, 2024

CD47 overexpression is related to tumour-associated macrophage infiltration and diffuse large B-cell lymphoma progression.

CD47 overexpression is related to tumour-associated macrophage infiltration and diffuse large B-cell lymphoma progression.

Journal: Clinical and translational medicine

Published: October 21, 2023

Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma.

Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma.

Journal: Blood advances

Published: August 10, 2023

Genomic and transcriptomic characterization reveals B-cell hyperactivation and immune evasion in hepatitis B virus-associated diffuse large B-cell lymphoma.

Genomic and transcriptomic characterization reveals B-cell hyperactivation and immune evasion in hepatitis B virus-associated diffuse large B-cell lymphoma.

Journal: Clinical and translational medicine

Published: March 06, 2023

Elevated serum IL-13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B-cell lymphoma.

Elevated serum IL-13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B-cell lymphoma.

Journal: Hematological oncology

Published: August 21, 2021

Implication of immune cell signature of tumor microenvironment in diffuse large B-cell lymphoma.

Implication of immune cell signature of tumor microenvironment in diffuse large B-cell lymphoma.

Journal: Hematological oncology

Published: March 24, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026